{"transactions":[{"id":730760,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T20:11:49.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":20275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":20275,"derivative":{"exercise_price":1.52,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":20275},"source":{"system":"sec-edgar","filing":"0000905148-26-003035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000090514826003035/form4.xml","form_type":"4"}},{"id":770244,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T20:35:52.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":9366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These RSUs shall vest in full on May 18, 2027, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":9366,"source":{"system":"sec-edgar","filing":"0000905148-26-002560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000090514826002560/form4.xml","form_type":"4"}},{"id":828346,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-25T21:04:44.000Z","date":"2026-03-24","kind":"grant","planned":false,"acquired":true,"shares":45867,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":45867,"derivative":{"exercise_price":1.36,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":45867},"source":{"system":"sec-edgar","filing":"0001193125-26-124313","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000119312526124313/ownership.xml","form_type":"4"}},{"id":1108345,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-17T21:49:31.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":20275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through the applicable vesting date."}],"balance_after":20275,"derivative":{"exercise_price":1.2,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":20275},"source":{"system":"sec-edgar","filing":"0000905148-25-002172","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000090514825002172/form4.xml","form_type":"4"}},{"id":1184014,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T12:58:35.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":36979,"price":0.98,"value":36239.42,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":36979,"derivative":{"exercise_price":0.98,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":36979},"source":{"system":"sec-edgar","filing":"0000950170-25-048895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000095017025048895/ownership.xml","form_type":"4"}},{"id":1487227,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T21:00:32.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000950170-24-070833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000095017024070833/ownership.xml","form_type":"4"}},{"id":1579095,"issuer":{"id":5986,"kind":"organization","name":"Pyxis Oncology, Inc.","symbol":"PYXS"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-13T20:54:35.000Z","date":"2024-03-12","kind":"grant","planned":false,"acquired":true,"shares":69760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in three equal annual installments beginning on the first anniversary of March 12, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":69760,"derivative":{"exercise_price":5.7,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":69760},"source":{"system":"sec-edgar","filing":"0000950170-24-030865","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000095017024030865/ownership.xml","form_type":"4"}},{"id":1592201,"issuer":{"id":573,"kind":"organization","name":"Acrivon Therapeutics, Inc.","symbol":"ACRV"},"owners":[{"id":36407,"kind":"person","name":"Palani Santhosh","position":1,"cik":"0002013475","reported_name":"Palani Santhosh","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-06T21:32:25.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in 36 substantially equal monthly installments beginning on March 4, 2024 (\"Vesting Commencement Date\"), such that all shares are fully vested on the third anniversary of the Vesting Commencement Date, in each case subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":32500,"derivative":{"exercise_price":5.05,"expiration_date":"2034-03-03","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0000905148-24-000904","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013475/000090514824000904/form4.xml","form_type":"4"}}]}